Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

An Intervention to Improve the Experience of Patients in Intermediate and Long-term Care Units

3 november 2026 uppdaterad av: Consorci Sanitari de l'Alt Penedès i Garraf

Study on the Impact of an Intervention to Improve the Experience of Patients Admitted to Intermediate and Long-term Care Units

The goal of this clinical trial is to learn if an intervention that detects and addresses the problems perceived by patients during their hospital stay can improve trust in the hospital among older patients admitted to intermediate and long-term care units. The main questions it aims to answer are:

  • Does the intervention increase patients' trust in the hospital, measured as their likelihood of recommending it?
  • Does the intervention reduce formal complaints, improve patients' emotional well-being, and improve the job satisfaction of nursing staff? Researchers will compare patients admitted before the intervention was introduced with patients admitted one year after it was introduced to see if trust in the hospital improves.

Participants will:

  • Complete, after one month of admission, the hospital's satisfaction questionnaire (which includes the trust question) and a short emotional well-being questionnaire, either themselves or through a relative or caregiver
  • In the post-intervention period, be interviewed between days 10 and 15 of admission about the negative aspects of their stay; the results are discussed at multidisciplinary team meetings, where corrective actions are agreed Nursing staff and nursing assistants on the participating wards will complete a job satisfaction questionnaire before and after the intervention.

Studieöversikt

Detaljerad beskrivning

This is a quasi-experimental before-and-after study. The primary outcome will be collected cross-sectionally from all eligible patients admitted at a given time before the intervention is implemented, and again from eligible patients admitted one year after implementation. Formal complaints will be collected retrospectively for the year before the intervention and for the intervention year. Patient questionnaires will be completed on paper without personal information and returned in a sealed envelope identified only by a participant code; the envelopes will be opened by independent research staff, and analysts will be blinded to the study period.

The primary analysis will compare the primary outcome between the pre- and post-intervention groups using a superiority approach, with parametric or non-parametric tests as appropriate and multivariable adjustment for potential confounders that differ between periods. Subgroup analyses by type of ward (conventional vs psychogeriatric) are planned. With 93 patients per group, the study has more than 80% power (two-sided alpha 0.05) to detect an increase in the proportion of patients with trust in the institution (score above 7) from 30% to 50%.

Studietyp

Observationell

Inskrivning (Beräknad)

186

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

  • Namn: Noemí Casaponsa
  • Telefonnummer: 43197 0034938960025
  • E-post: recerca@csapg.cat

Studieorter

    • Barcelona
      • Vilanova i la Geltrú, Barcelona, Spanien
        • Rekrytering
        • Hospital Sant Antoni Abat-Consorci Sanitari Alt Penedès-Garraf
        • Kontakt:
        • Huvudutredare:
          • Helena Camell

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Patients admitted to intermediate and long-term care units

Beskrivning

Inclusion Criteria:

  • Admitted to an intermediate or long-term care unit of Hospital Sant Antoni Abat
  • Length of stay of at least 1 month
  • Patient and/or caregiver able to take part in the study assessments
  • Signed informed consent, given by the patient or by the patient's legal representative

Exclusion Criteria:

  • Cognitive or affective disorder that limits the ability to answer the study questionnaires, with no reference person available to answer on the patient's behalf
  • Participation in another study involving an experimental intervention during the period of this study and/or with a visit schedule incompatible with this study

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: OTHER
  • Tidsperspektiv: PROSPECTIVE

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Pre-intervention

Patients admitted to intermediate and long-term care units before the intervention is implemented, receiving usual care

Post-intervention

Patients admitted to the same units one year after the intervention is implemented

Between days 10 and 15 of admission, patients (or their relatives or caregivers) are interviewed following a structured script about the negative aspects they perceive in their hospital stay, including quality of care, comfort, medical information, and assistance with daily activities. Responses are classified using the Net Promoter Score framework. The results are presented at the periodic multidisciplinary team meetings, where a personalized action plan is agreed, documented in the clinical record with assigned responsibilities and deadlines, and reassessed at approximately 30 days.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Trust in the institution
Tidsram: After 1 month of admission, in the pre-intervention group and in the post-intervention group

Score on the question "If needed, would you recommend Hospital Sant Antoni Abat?" from the hospital's inpatient satisfaction questionnaire, rated from 0 (would never recommend) to 10 (would actively recommend). Higher scores indicate greater trust. A score above 7 is considered to indicate trust in the institution.

After 1 month of admission, in the pre-intervention group and in the post-intervention group

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

21 november 2025

Primärt slutförande (Beräknad)

31 december 2027

Avslutad studie (Beräknad)

31 december 2027

Studieregistreringsdatum

Först inskickad

3 november 2026

Först inskickad som uppfyllde QC-kriterierna

3 november 2026

Första postat (Faktisk)

9 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

9 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • CSAPG-83

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Tidsram för IPD-delning

After publication of main results of the study

Kriterier för IPD Sharing Access

IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera